For Zymeworks Inc. (ZYME), 2025 was a banner year, with the stock registering an impressive 100% gain. The company's growth has been fueled by strategic partnerships and a steady stream of royalties and milestone payments - key metrics that define its success. Can the company sustain this momentum and continue turning partnerships into profits?Company ProfileZymeworks is a global biotechnology com...
For comments and feedback contact: editorial@rttnews.com
May 15, 2026 15:25 ET Apart from the confirmation of Kevin Warsh as the next Fed chair, the main news on the economics front this week included key price data from the U.S. and the first quarter economic growth figures from major economies. Both consumer prices and producer costs have started to reflect the effect of supply shocks due to the Middle East conflict. In Europe, GDP data was in focus, while inflation data from China dominated the news flow in Asia.